Literature DB >> 30805994

Macrophage colony-stimulating factor pretreatment of bone marrow progenitor cells regulates osteoclast differentiation based upon the stage of myeloid development.

Xuehui Yang1, Shivangi Pande1,2, Cameron Scott3, Robert Friesel1,2.   

Abstract

Osteoclasts (OCs) are large, multinucleated bone resorbing cells originating from the bone marrow myeloid lineage, and share a common progenitor with macrophages and dendritic cells. Bone marrow cells (BMCs) are a common source for in vitro osteoclastogenesis assays but are a highly heterogeneous mixture of cells. Protocols for in vitro osteoclastogenesis vary considerably thus hindering interpretation and comparison of results between studies. Macrophage colony-stimulating factor (M-CSF) pretreatment is commonly used to expand OC progenitors (OCPs) in BMC cultures before in vitro differentiation. However, the failure of osteoclastogenesis of M-CSF primed bone marrow myeloid blasts has been reported. In this study, we used a simple method of differential adherence to plastic to enrich OCP from mouse BMCs. We found that M-CSF pretreatment of plastic-adherent BMCs (adBMCs) increased the number of CD11b-F4/80+ macrophages and decreased the number of CD11b+ monocytes resulting in decreased OC formation. M-CSF pretreatment of purified c-Kit+ progenitors weakly inhibited OC formation, whereas M-CSF pretreatment of purified c-Kit-CD11b+ progenitors promoted the formation of large OC. M-CSF pretreatment increased the proliferation of both purified c-Kit+ and c-Kit-CD11b+ cells and increased the percentage of CD11b-F4/80+ cells from c-Kit+ progenitors. In addition, M-CSF pretreatment increased the percentage of CD11b+ F4/80- cells from purified c-Kit-CD11b+ cells. M-CSF pretreatment increased the percentage of CD14 + CD16 + intermediate monocytes and subsequent OC formation from human 2adBMCs, and increased OC formation of purified CD14 + cells. Together, these results indicate that in vitro OCP expansion in the presence of M-CSF and bone marrow stromal cells is dependent upon the developmental stage of myeloid cells, in which M-CSF favors macrophage differentiation of multipotent progenitors, promotes monocyte maturation and supports differentiation of late-stage OCP cells.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  CD11b; CD14; CD16; c-Kit; macrophage colony-stimulating factor (M-CSF); osteoclast progenitor (OCP); osteoclastogenesis

Year:  2019        PMID: 30805994      PMCID: PMC6570541          DOI: 10.1002/jcb.28512

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  28 in total

1.  Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts.

Authors:  S Takeshita; K Kaji; A Kudo
Journal:  J Bone Miner Res       Date:  2000-08       Impact factor: 6.741

Review 2.  Genetic regulation of osteoclast development and function.

Authors:  Steven L Teitelbaum; F Patrick Ross
Journal:  Nat Rev Genet       Date:  2003-08       Impact factor: 53.242

Review 3.  A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function.

Authors:  N Takahashi; N Udagawa; T Suda
Journal:  Biochem Biophys Res Commun       Date:  1999-03-24       Impact factor: 3.575

Review 4.  The CD14+ CD16+ blood monocytes: their role in infection and inflammation.

Authors:  Loems Ziegler-Heitbrock
Journal:  J Leukoc Biol       Date:  2006-11-29       Impact factor: 4.962

5.  Bifurcation of osteoclasts and dendritic cells from common progenitors.

Authors:  T Miyamoto; O Ohneda; F Arai; K Iwamoto; S Okada; K Takagi; D M Anderson; T Suda
Journal:  Blood       Date:  2001-10-15       Impact factor: 22.113

6.  Mechanisms of osteoclast dysfunction in human osteopetrosis: abnormal osteoclastogenesis and lack of osteoclast-specific adhesion structures.

Authors:  A Teti; S Migliaccio; A Taranta; S Bernardini; G De Rossi; M Luciani; M Iacobini; L De Felice; R Boldrini; C Bosman; A Corsi; P Bianco
Journal:  J Bone Miner Res       Date:  1999-12       Impact factor: 6.741

7.  Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts.

Authors:  Yukiko Komano; Toshihiro Nanki; Kenji Hayashida; Ken Taniguchi; Nobuyuki Miyasaka
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

8.  Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.

Authors:  K Kobayashi; N Takahashi; E Jimi; N Udagawa; M Takami; S Kotake; N Nakagawa; M Kinosaki; K Yamaguchi; N Shima; H Yasuda; T Morinaga; K Higashio; T J Martin; T Suda
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

9.  Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors.

Authors:  F Arai; T Miyamoto; O Ohneda; T Inada; T Sudo; K Brasel; T Miyata; D M Anderson; T Suda
Journal:  J Exp Med       Date:  1999-12-20       Impact factor: 14.307

10.  Human primary osteoclasts: in vitro generation and applications as pharmacological and clinical assay.

Authors:  Mira Susa; Ngoc-Hong Luong-Nguyen; David Cappellen; Natasa Zamurovic; Rainer Gamse
Journal:  J Transl Med       Date:  2004-03-16       Impact factor: 5.531

View more
  2 in total

Review 1.  Bone remodeling: an operational process ensuring survival and bone mechanical competence.

Authors:  Simona Bolamperti; Isabella Villa; Alessandro Rubinacci
Journal:  Bone Res       Date:  2022-07-18       Impact factor: 13.362

Review 2.  The Multiple Biological Functions of Dipeptidyl Peptidase-4 in Bone Metabolism.

Authors:  Qiu Yang; Bing Fu; Dan Luo; Haibo Wang; Hongyi Cao; Xiang Chen; Li Tian; Xijie Yu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-02       Impact factor: 6.055

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.